EMS Prehospital Blood Culture Collection and Antibiotic Administration: A Two-Phase Pilot Project to Reduce Mortality in Patients With Severe Sepsis and Septic Shock
NCT04134624 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 215
Last updated 2021-09-22
Summary
This study is designed to improve the outcomes for patients suffering from severe sepsis and septic shock (SS/SS) by decreasing the time from first medical contact to antibiotic administration. This is a stepwise study that aims to demonstrate the ability of paramedics to accurately obtain blood cultures prior to hospital arrival, administer a broad spectrum antibiotic and initiate IV fluid resuscitation in patients meeting predefined criteria for SS/SS.
Conditions
- Sepsis
- Sepsis, Severe
- Septic Shock
Interventions
- OTHER
-
Sepsis care bundle
Initiation of sepsis care bundle in prehospital setting, including collection of blood cultures, administration of antibiotics, and initiation of IV fluids
Sponsors & Collaborators
-
HealthPartners Institute
lead OTHER
Principal Investigators
-
Aaron Burnett, MD · HealthPartners Institute
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-09-11
- Primary Completion
- 2020-02-27
- Completion
- 2021-07-08
Countries
- United States
Study Locations
More Related Trials
-
Safety, Pharmacokinetics and Pharmacodynamics of BMS-936559 in Severe Sepsis
NCT02576457 ·Status: TERMINATED ·Phase: PHASE1
-
Population Pharmacokinetics and Monte Carlo Dosing Simulations of Meropenem During the Early Phase of Severe Sepsis and Septic Shock in Critically Ill Patients in Intensive Care Units
NCT02213796 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Outcome Study of High-dose Meropenem in Sepsis and Septic Shock Patients
NCT03344627 ·Status: COMPLETED ·Phase: NA
-
LifeFlow Sepsis Study
NCT07191054 ·Status: WITHDRAWN ·Phase: NA
-
GR270773 In The Treatment Of Suspected Or Confirmed Gram-Negative Severe Sepsis In Adults
NCT00089986 ·Status: COMPLETED ·Phase: PHASE2
-
Rapid Treatment of Shock Without Trauma
NCT05073354 ·Status: COMPLETED
-
The Effect of Lactate Clearance Oriented Haemodynamic Therapy on the Outcome of Patients With Septic Shock
NCT02566460 ·Status: COMPLETED ·Phase: NA
-
Piperacillin/Tazobactam in Critically Ill Patients With Severe Sepsis and Septic Shock
NCT02730624 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Procalcitonin Guided Antibiotic Therapy in Adult Intensive Care Units (ICU's)
NCT01139489 ·Status: COMPLETED ·Phase: NA
-
Prolonged Intravenous Infusion of β-lactam Antibiotics in Early Septic Patients
NCT05024565 ·Status: UNKNOWN ·Phase: NA
-
Open-label Evaluation of Polymyxin B Hemoperfusion for Septic Shock
NCT02825329 ·Status: TEMPORARILY_NOT_AVAILABLE
-
Therapeutic Plasma Exchange in Adult Patients With Severe Sepsis
NCT04057872 ·Status: COMPLETED ·Phase: PHASE1
-
Methylene Blue and Microcirculation in Septic Shock
NCT04295993 ·Status: UNKNOWN ·Phase: PHASE3
-
Protocolized Reduction of Non-resuscitation Fluids Versus Usual Care in Septic Shock Patients
NCT06140147 ·Status: RECRUITING ·Phase: NA
-
Early Methylene Blue in the Microhemodynamics of Septic Patients
NCT07264543 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
The Effect of Etomidate on Patient Outcomes After Single Bolus Doses
NCT00441792 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Polymyxin B Hemoperfusion (PMX) for Endotoxemic Septic Shock in a Randomized, Open-Label Study
NCT03901807 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Effect of Rapid Fluid Challenge Under Pulmonary Artery Catheter Monitoring on Physiological Indexes of Patients With Septic Shock
NCT03661268 ·Status: UNKNOWN ·Phase: NA
-
Methylene Blue in Sepsis: A Randomized Controlled Trial
NCT00486174 ·Status: WITHDRAWN ·Phase: NA
-
Impact of a Prehospital Sepsis Protocol on Timely Antibiotic Administration and Subsequent Adverse Events
NCT05502107 ·Status: COMPLETED ·Phase: NA
-
Investigate the Activity of Endotoxin in Severe Sepsis
NCT01957254 ·Status: TERMINATED
-
Therapeutic Plasma Exchange in Septic Shock: A Pilot Study
NCT05093075 ·Status: RECRUITING ·Phase: PHASE2
-
A Safety and Efficacy Study of Intravenous E5564 in Patients With Severe Sepsis
NCT00046072 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Methylene Blue in the Treatment of Severe Septic Shock
NCT06481410 ·Status: RECRUITING ·Phase: NA
-
Endotoxin Activity Assay and Microcirculation in Severe Sepsis
NCT02452138 ·Status: UNKNOWN